Absence of a detectable peripheral blood immune signature at VAP onset: a matched case-control proof-of-concept study

Ventilator-associated pneumonia (VAP) is the most frequent infectious respiratory complication among intensive care unit (ICU) patients, yet its diagnosis remains challenging due to the absence of reliable gold-standard tools. This study investigated systemic transcriptomic and cytokine responses during VAP occurring between day 5–7 after ICU admission to identify potential blood-based biomarkers. We conducted a matched case–control retrospective analysis nested within a multicenter, prospective, non-interventional ICU cohort collected between December 2009 and June 2011. We selected mechanically ventilated patients who developed VAP, diagnosed according to the American Thoracic Society criteria, with episodes occurring between day 5 and day 7 after ICU admission. Fourteen VAP patients were matched with twenty-eight non-VAP controls based on demographics, severity scores, and admission characteristics. Whole blood RNA sequencing and multiplex plasma cytokine quantification were performed to characterize systemic immune profiles. The median duration of mechanical ventilation was 7 days, and ICU mortality reached 24%. No significant differentially expressed genes or cytokine level differences were identified when comparing VAP and non-VAP patients. As our cohort comprised sepsis and trauma patients, we performed similar analyses by subgroups and still observed no differences between VAP and non-VAP patients. In conclusion, despite several analyses, we were unable to detect systemic immune-related differences between VAP and non-VAP patients within this cohort. Consistent with previous reports, these findings support the hypothesis of a predominantly localized host response, which should be considered in the design of future VAP biomarker discovery studies.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-16
DOI
https://doi.org/10.3389/fmed.2026.1854967
Primary Topic
Nosocomial Infections in ICU
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Absence of a detectable peripheral blood immune signature at VAP onset: a matched case-control proof-of-concept study

Guillaume Monneret, Elisabeth Cerrato, Valérie Cheynet, Emilie Vernay et al.
1 links
Frontiers in Medicine
Nosocomial Infections in ICU
article

Absence of a detectable peripheral blood immune signature at VAP onset: a matched case-control proof-of-concept study

Guillaume Monneret, Elisabeth Cerrato, Valérie Cheynet, Emilie Vernay, Anne-Claire Lukaszewicz, Jean-François Llitjos
article en

Abstract

Ventilator-associated pneumonia (VAP) is the most frequent infectious respiratory complication among intensive care unit (ICU) patients, yet its diagnosis remains challenging due to the absence of reliable gold-standard tools. This study investigated systemic transcriptomic and cytokine responses during VAP occurring between day 5–7 after ICU admission to identify potential blood-based biomarkers. We conducted a matched case–control retrospective analysis nested within a multicenter, prospective, non-interventional ICU cohort collected between December 2009 and June 2011. We selected mechanically ventilated patients who developed VAP, diagnosed according to the American Thoracic Society criteria, with episodes occurring between day 5 and day 7 after ICU admission. Fourteen VAP patients were matched with twenty-eight non-VAP controls based on demographics, severity scores, and admission characteristics. Whole blood RNA sequencing and multiplex plasma cytokine quantification were performed to characterize systemic immune profiles. The median duration of mechanical ventilation was 7 days, and ICU mortality reached 24%. No significant differentially expressed genes or cytokine level differences were identified when comparing VAP and non-VAP patients. As our cohort comprised sepsis and trauma patients, we performed similar analyses by subgroups and still observed no differences between VAP and non-VAP patients. In conclusion, despite several analyses, we were unable to detect systemic immune-related differences between VAP and non-VAP patients within this cohort. Consistent with previous reports, these findings support the hypothesis of a predominantly localized host response, which should be considered in the design of future VAP biomarker discovery studies.

Frontiers in MedicineVol. 13
Université Claude Bernard Lyon 1 (FR), Lyon College (US), Hospices Civils de Lyon (FR), Hôpital Edouard Herriot (FR), bioMérieux (France) (FR), Physiopathologie de l'immunodépression associée aux réponses inflammatoires systémiques (FR), bioMérieux (United Kingdom) (GB)
Good health and well-being
Nosocomial Infections in ICU
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon